Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereof

Details for Australian Patent Application No. 2008329518 (hide)

Owner Viventia Biotech Inc.

Inventors Chahal, Francina C.; Cizeau, Jeannick

Agent Davies Collison Cave

Pub. Number AU-A-2008329518

PCT Pub. Number WO2009/067800

Priority 60/990,494 27.11.07 US

Filing date 27 November 2008

Wipo publication date 4 June 2009

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/067800 Priority application(s): WO2009/067800

16 August 2012 Assignment before Grant

  Viventia Biotech Inc. The application has been assigned to Viventia Biotechnologies Inc. 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008329529-14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis

2008329515-Cysteine protease inhibitors for the treatment of parasitic diseases